Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

Benzer Materyaller

• Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma.
  Yazar:: June Y Hou, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)
• Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
  Yazar:: Hou, June Y., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
  Yazar:: Samaraweera, Leleesha, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice
  Yazar:: Huang, Gloria S., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines
  Yazar:: McDaid, Hayley M., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)